Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIMEPRAZINE vs TROFOSFAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIMEPRAZINE vs TROFOSFAMIDE: Safety Overview

Metric TRIMEPRAZINE TROFOSFAMIDE
Total FAERS Reports 3,601 109
Deaths Reported 548 19
Death Rate 15.2% 17.4%
Hospitalizations 2,280 35
Average Patient Age 43.9 yrs 55.1 yrs
% Female Patients 57.1% 36.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Marketing Status Discontinued N/A